Related Experiment Video
Updated: Aug 12, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Cefuroxime plasma and CSF levels in children with meningitis
Archives of Disease in Childhood
|March 1, 1979
Insights
Cefuroxime effectively treated bacterial meningitis in children, achieving good drug levels in blood and cerebrospinal fluid (CSF). All patients recovered fully with no observed side effects, indicating a safe and effective therapeutic option.
Area of Science:
- Pediatric infectious diseases
- Pharmacokinetics and pharmacodynamics
- Bacterial meningitis treatment
Background:
- Bacterial meningitis remains a significant cause of childhood morbidity and mortality.
- Optimal antibiotic therapy is crucial for effective treatment and minimizing long-term sequelae.
- Cefuroxime is a second-generation cephalosporin with broad-spectrum activity against common bacterial meningitis pathogens.
Purpose of the Study:
- To evaluate the efficacy and safety of cefuroxime in pediatric patients diagnosed with bacterial meningitis.
- To determine the pharmacokinetic profile of cefuroxime, specifically blood and cerebrospinal fluid (CSF) levels, in children with bacterial meningitis.
Main Methods:
- A cohort of 7 pediatric patients with bacterial meningitis received intravenous cefuroxime at a dosage of 25 mg/kg every four hours.
- Therapeutic drug monitoring was performed by measuring cefuroxime concentrations in blood and CSF samples.
- Clinical outcomes, including recovery and adverse events, were closely monitored.
Main Results:
- Intravenous cefuroxime administration resulted in satisfactory therapeutic concentrations of the antibiotic in both blood and CSF.
- All 7 pediatric patients treated with cefuroxime achieved a full clinical recovery.
- No adverse side effects were reported during the treatment course, suggesting a favorable safety profile.
Conclusions:
- Cefuroxime demonstrates efficacy and safety as a treatment for bacterial meningitis in children.
- Achieving adequate therapeutic blood and CSF levels of cefuroxime is associated with successful patient outcomes.
- Further research may support cefuroxime as a viable therapeutic option in pediatric bacterial meningitis management.
Abstract:
Cefuroxime (25 mg/kg) given intravenously every four hours to 7 children with bacterial meningitis resulted in satisfactory therapeutic blood and CSF levels. All children made a full recovery and side effects were absent.
Related Concept Videos
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
01:26Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
01:18Viral Meningitis
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
01:27Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
01:22Bacterial Meningitis I: Introduction
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...